期刊文献+

血小板裂解液差异蛋白在原发免疫性血小板减少症诊断中的临床应用研究

Study of clinical study of platelet lysate differential protein in diagnosis of primary immune thrombocytopenia
下载PDF
导出
摘要 目的通过对原发免疫性血小板减少症(ITP)患者血小板裂解液差异蛋白的研究,了解其与ITP发病的关系,为ITP的诊断建立一种简便快速、灵敏度高、特异性好的实验方法。方法应用表面增强激光解吸电离飞行时间质谱(SELDI-TOF-MS)技术检测64例ITP患者及42例健康者血小板裂解液,获得血小板蛋白质谱图,筛选出差异蛋白,结合人工神经网络(ANN),建立ITP诊断模型。结果质荷比(m/z)为3 549.17、7 678.09的蛋白在ITP组中高表达,质荷比为5 328.29、7 894.32的蛋白低表达。诊断模型的灵敏度93.3%,特异度82.6%。结论基于血小板蛋白质谱建立的ANN模型可能对ITP的诊断具有一定的临床价值。 Objective To establish a quick and simple diagnostic laboratory method.with high sensitivity and good specificity for the diagnosis of primary immune thromboeytopenia ITP by studying platelet lysate differential protein ih the patients with ITP for understanding its relationship with the onset of ITP. Methods The platelet ly- sate was detected in 64 cases of ITP and 42 cases of healthy people by surface enhanced laser desorption/ionization- time of flight-mass spectrometry(SELDI-TOF-MS) technology for obtaining the platelet protein mass spectrum. The differential protein was screened and combined with the artificial neural network(ANN) for establishing the diagnos tic model of ITP. Results The protein with the mass electron ratio(m/z) of 3 549.17 and 7 678.09 was highly ex pressed in the ITP group and which of m/z 5 328.29 and 7 894.32 was lowly expressed. The sensitivity and specifici- ty of the diagnostic model were 93.3% and 82.6 % respectively. Conclusion The established ANN model on the ba- sis of platelet protein mass spectrum may have some clinical value for the diagnosis of ITP.
出处 《检验医学与临床》 CAS 2015年第16期2346-2348,共3页 Laboratory Medicine and Clinic
基金 泸州医学院青年基金项目(12065)
关键词 原发免疫性血小板减少症 蛋白质组学 表面增强激光解吸电离飞行时间质谱 primary immune thrombocytopenia proteomics SELDI-TOF-MS
  • 相关文献

参考文献13

  • 1Stasi R, Newland AC. ITP : a historical perspective[J]. Br J Haematol,2011,153(4):437-450.
  • 2Nugent D, Mcmillan R, Nichol JL, et al. Pathogenesis of chronic immune thrombocytopenia:increased platelet de struction and/or decreased platelet production[J]. Br J Haematol,2009,146(6) : 585- 596.
  • 3Rodeghiero F. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpu- ra of adults and children: report from an international working group[J]. Blood,2009,113(11) :2386-2393.
  • 4He Y,Zhao YX,Zhu MQ,et al. Detection of autoantibod- ies against platelet glycoproteins in patients with immune thrombocytopenic purpura by flow cytometric immuno- bead array[J]. Clin Chim Acta,2013,415(1) : 176-180.
  • 5De BM, De SD, Meuwis MA, et al. Chal.lenges for biomar- ker discovery in body fluids using SELDI-TOF-MS[J]. Biomed Biotechnol, 2010,2010 : 906082.
  • 6Craddock RM, Huang JT,Jackson E, et al. Increased al- pha-defensins as a blood marker for schizophrenia suscep tibility[J]. Mol Cell Proteomics, 2008,7 ( 7 ) : 1204-1213.
  • 7Rolland D. Identification of proteomic signatures of man- tle cell lymphoma, small lymphocytic lymphoma,and mar ginal zone iymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry [J]. Leuk Lymphoma, 2011,52 (4) : 648-658.
  • 8Tumblin A. Apolipoprotein AI and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease[J]. Haematologica, 2010, 95(9) : 1467-1472.
  • 9Ono A, Naito T, Ito I, et al. Correlations between serial pro-gastrin-releasing peptide and neuron specific enolase levels,and the radiological response to treatment and sur vival of patients with small-cell lung cancer [J]. Lung Cancer,2012,76(3) :439-444.
  • 10Peeters K, Loyen S, Van Kerckhoven S, et al. Thrombo- poietic effect of VPAC1 inhibition during megakaryopoie- sis[J]. Br J Haematol,2010,151(1) :54-61.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部